The Peer-Review System: Pique. and Critique

In 1978, physicist Richard A. Muller of Berkeley was awarded two distinguished prizes—the Waterman Award and the Texas Instruments Foundation Founders’ Prize—for his research on cosmic rays and adaptive optics. The event was particularly notable because Muller had been refused support for this work after peer review by the National Science Foundation, the Department of Energy, the National Aeronautics and Space Administration, and the Department of Defense. Many innovative

Written byCarl Leopold
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

In 1978, physicist Richard A. Muller of Berkeley was awarded two distinguished prizes—the Waterman Award and the Texas Instruments Foundation Founders’ Prize—for his research on cosmic rays and adaptive optics. The event was particularly notable because Muller had been refused support for this work after peer review by the National Science Foundation, the Department of Energy, the National Aeronautics and Space Administration, and the Department of Defense.

Many innovative research projects fail to pass muster under the peer-review system, and, as in this case, the work has to be done without specific funding. Is this a failure of the peer-review system? What are the system’s other costs? The questions are especially appropriate because peer review is almost universally required now for decisions on research proposals, journal publications, and promotions for academic people.

There are substantial costs to peer review in terms of the time investment. A study by NSF in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies